Atosiban Acetate | CAS:914453-95-5

We serve Atosiban Acetate CAS:914453-95-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Atosiban Acetate

Chemical Name:Atosiban Acetate
CAS.NO:914453-95-5
Synonyms:Atosiban Acetate
 
Physical and Chemical Properties:
Molecular Formula C45H71N11O14S2
Molecular Weight 1054.240
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Atosiban acetate is a competitive oxytocin and vasopressin antagonist by exhibiting high affinity for both receptors. It is used to treat preterm labors.



Contact us for information like Atosiban Acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Atosiban Acetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Atosiban Acetate Use and application,Atosiban Acetate technical grade,usp/ep/jp grade.


Related News: Cases recorded in Thailand, Taiwan, Germany, Vietnam, Japan, France and the United States involved patients who had not been to China.1-Chlorooctane manufacturer To date, eight cases have been confirmed in the US: three people in California, two in Illinois and one individual each in Massachusetts, Washington State, and Arizona.[4-(trifluoromethyl)phenyl]methanol supplier As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.Ethyl 5-bromobenzofuran-2-carboxylate vendor As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.Slower growth in pesticide intermediates weighed on industrial business. In the first three quarters, the company’s operating income was 2.977 billion yuan, a year-on-year increase of 2.57%.